Search Results - Raul Braylan
- Showing 1 - 2 results of 2
-
1
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma by Neha Korde, Mattias Carlsten, Min-Jung Lee, Alex Minter, Esther Tan, Mary Kwok, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mark Roschewski, Adriana Zingone, Rene Costello, Marcia Mulquin, Diamond Zuchlinski, Irina Maric, Katherine R. Calvo, Raul Braylan, Prashant Tembhare, Constance Yuan, Maryalice Stetler-Stevenson, Jane Trepel, Richard Childs, Ola Landgren
Published in Haematologica (2014-06-01)Get full text
Article -
2
CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy by Nisha Patel, Adam Lamble, Ilan Kirsch, Haneen Shalabi, Hao-Wei Wang, Sara K. Silbert, Samantha Scanlon, Constance M Yuan, Alyssa Doverte, Jake Wellek, Raul Braylan, Mark Ahlman, Evrim B Turkbey, Sandra D Bohling, Karen M Chisholm, Murat Alp Oztek, Mike LaLoggia, Anupam Verma, Alexandra E Kovach, Brent L Wood, Kasey Leger, Nirali N. Shah
Published in Journal for ImmunoTherapy of Cancer (2024-10-01)Get full text
Article
